In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Đorđe ZlatkovićNational Reference Laboratory for Toxoplasmosis, Group for Microbiology and Parasitology, Center of Excellence for Food- and Vector-born Zoonosis, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11129 Belgrade, Serbia.ORCID 0009-0004-9735-3191 Vladimir DobričićDepartment of Pharmaceutical Chemistry, University of Belgrade-Faculty of Pharmacy, Vojvode Stepe 450, 11000 Belgrade, Serbia.ORCID 0000-0002-5086-9017 Jelena SrbljanovićNational Reference Laboratory for Toxoplasmosis, Group for Microbiology and Parasitology, Center of Excellence for Food- and Vector-born Zoonosis, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11129 Belgrade, Serbia.
Olivera LijeskićNational Reference Laboratory for Toxoplasmosis, Group for Microbiology and Parasitology, Center of Excellence for Food- and Vector-born Zoonosis, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11129 Belgrade, Serbia.ORCID 0000-0002-9009-1924 Neda BaumanNational Reference Laboratory for Toxoplasmosis, Group for Microbiology and Parasitology, Center of Excellence for Food- and Vector-born Zoonosis, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11129 Belgrade, Serbia.ORCID 0000-0002-4162-0703 Vladimir ĆirkovićNational Reference Laboratory for Toxoplasmosis, Group for Microbiology and Parasitology, Center of Excellence for Food- and Vector-born Zoonosis, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11129 Belgrade, Serbia.ORCID 0000-0002-3514-5328 Tijana ŠtajnerNational Reference Laboratory for Toxoplasmosis, Group for Microbiology and Parasitology, Center of Excellence for Food- and Vector-born Zoonosis, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11129 Belgrade, Serbia.ORCID 0000-0003-3291-6104 Funding
Science Fund of the Republic of Serbia, 7328, Reinvention of the diagnostic algorithm and treat-ment options for reactivated toxoplasmosis-ToxoReTREAT 7328
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cytotoxicityN-(9-acridinyl) amino acid derivativessynthesisToxoplasma gondii
Identifiers
PMID40143037
PMCPMC11944910
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390